Jun 25, 2021 / 08:00PM GMT
Operator
Greetings, and welcome to the Annual Meeting of Kezar Life Sciences. At this time our participants are in listen only mode. A brief question-and-answer session will follow the formal business of this meeting. The question may be submitted in [biding] using the online portal. As a reminder, this meeting is being recorded. It is now my pleasure to introduce today's host, John Fowler. Thank you. You may begin.
John Fowler - Kezar Life Sciences, Inc. - Co-Founder & CEO
Thank you, and good afternoon, ladies and gentlemen. I'm John Fowler, CEO of Kezar Life Sciences and this meeting is called to order. It's my pleasure on behalf of the Board of Directors and management of Kezar to extend you a warm welcome and express our appreciation for attending this meeting. We've already supplied each stockholder with a copy of our proxy statement and annual report. And electronic copies are available on the virtual meeting platform to any stockholder who doesn't have one.
The principal business of this meeting is to consider and vote upon two matters set forth in
Kezar Life Sciences Inc Annual Shareholders Meeting Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot